TEAM ARCHIVE / 2011-05-26

Chroma receives final ANVISA authorization with Apramed

Historical report translated and adapted from the team’s archive. Events, company activities and regulatory references describe the original period.

The company at the time and its commercial and industrial partner Apramed obtained final ANVISA registration for Chroma. The first phase had been approved in 2009, but additional software-quality documentation was required under newer, stricter authorization criteria.

In May 2011, ANVISA published the definitive Chroma authorization in Brazil’s Federal Official Gazette, issue 97, dated Monday, May 23, 2011. This is a historical product milestone, rather than a claim about EVOptica’s current regulatory status.

THE NEXT CHAPTER IN OPHTHALMIC TECHNOLOGY

Find the right instrument
for your practice.

Contact sales ↗